Screening for new inhibitors of the human Mitochondrial Pyruvate Carrier and their effects on hepatic glucose production and diabetes

糖异生 糖酵解 葡萄糖摄取 生物化学 碳水化合物代谢 药理学 生物 化学 内科学 内分泌学 新陈代谢 医学 胰岛素
作者
Sébastien Herzig,Lingzi Li,Cecilia Jiménez‐Sánchez,Jean‐Claude Martinou,Pierre Maechler
出处
期刊:Biochimica Et Biophysica Acta - General Subjects [Elsevier BV]
卷期号:1867 (12): 130492-130492 被引量:2
标识
DOI:10.1016/j.bbagen.2023.130492
摘要

The mitochondrial pyruvate carrier (MPC) is a protein complex composed of two subunits, MPC1 and MPC2. This carrier is at the interface between glycolysis and mitochondrial metabolism and plays an essential role in hepatic glucose production.Here we describe an in vitro screen for small molecule inhibitors of the MPC using a strain of Lactococcus lactis that has been engineered to co-express the two subunits of the human MPC and is able to import exogenous 14C-pyruvate. We then tested the top candidates for potential antidiabetic effects through the repression of gluconeogenesis.By screening the Prestwick compound library of 1'200 drugs approved by the Food and Drug Administration for inhibitors of pyruvate uptake, twelve hit molecules were identified. In a secondary screen, the most potent inhibitors were found to inhibit pyruvate-driven oxygen consumption in mouse C2C12 muscle cells. Assessment of gluconeogenesis showed that Zaprinast, as well as the established MPC inhibitor UK5099, inhibited in vitro and in vivo hepatic glucose production. However, when tested acutely in mice without the administration of gluconeogenic substrates, MPC inhibitors raised blood glucose levels, pointing to liver-independent effects. Furthermore, chronic treatment with Zaprinast failed to correct hyperglycemia in both lean and obese diabetic mouse models.New MPC inhibitors have been identified, showing inhibitory effects on hepatic glucose production.For potential antidiabetic applications, MPC inhibitors should target the liver without undesired inhibition of mitochondrial pyruvate metabolism in the skeletal muscles or pancreatic beta-cells in order to avoid dual effects on glycemia.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
DD发布了新的文献求助10
刚刚
freecare发布了新的文献求助10
刚刚
NexusExplorer的应助被梁小伟采纳,获得10
刚刚
无糖加冰完成签到,获得积分10
刚刚
1秒前
Yuyu001发布了新的文献求助80
1秒前
珍蚌好命女完成签到,获得积分10
1秒前
inertia完成签到,获得积分10
1秒前
1秒前
1秒前
2秒前
2秒前
MUMU发布了新的文献求助10
3秒前
bm023061发布了新的文献求助10
4秒前
沐风发布了新的文献求助10
4秒前
情怀的应助被枫丶采纳,获得10
5秒前
5秒前
5秒前
lishihao发布了新的文献求助10
5秒前
6秒前
6秒前
6秒前
单薄惜天完成签到 ,获得积分10
6秒前
李健的应助被沃柑采纳,获得10
7秒前
所所的应助被当康康采纳,获得10
7秒前
8秒前
Min发布了新的文献求助10
8秒前
meng发布了新的文献求助10
9秒前
YM完成签到,获得积分10
9秒前
Qin发布了新的文献求助10
9秒前
失眠孤兰发布了新的文献求助10
12秒前
辣个男人发布了新的文献求助10
13秒前
FashionBoy的应助被胡萝卜卜采纳,获得10
13秒前
13秒前
13秒前
搜集达人的应助被liugm采纳,获得10
14秒前
Hiccup完成签到,获得积分10
14秒前
bbf完成签到,获得积分10
14秒前
14秒前
慕青的应助被梦寐寤寐采纳,获得10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8193425
求助须知:如何正确求助?哪些是违规求助? 9579620
关于积分的说明 21866505
捐赠科研通 7793025
什么是DOI,文献DOI怎么找? 3437297
关于科研通互助平台的介绍 2560718
邀请新用户注册赠送积分活动 2484128